CDSCO Panel Approves Pfizer Protocol Amendment proposal to study anti-cancer drug Elranatamab Dr. Divya Colin4 Nov 2024 5:45 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
Shilpa Medicare gets four USFDA observations for Bengaluru facility Ruchika Sharma4 Nov 2024 3:58 PM ISTRaichur: Shilpa Medicare has announced that the US Food and Drug Administration (USFDA) has issued Form 483 with four observations at the...
Biocon Biologics Bengaluru drug substance facility classified as VAI Ruchika Sharma4 Nov 2024 12:30 PM ISTBengaluru: Biocon has announced that the U.S. Food and Drug Administration (USFDA) has classified Biocon Biologics' Drug Substance Facility at Biocon...
USFDA classifies Cipla Goa facility as VAI Ruchika Sharma4 Nov 2024 11:30 AM ISTMumbai: Through a recent BSE filing, Cipla has informed that the United States Food and Drug Administration (USFDA) has classified the routine...
Sanofi Healthcare Gets CDSCO Panel Nod to Study Asthma Drug SAR443765 Dr. Divya Colin3 Nov 2024 5:15 PM ISTNew Delhi: The drug major Sanofi Healthcare has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Intas Pharmaceutical Gets CDSCO Panels Nod to Conduct Phase III clinical trial of Ruxolitinib cream Dr. Divya Colin3 Nov 2024 5:00 PM ISTNew Delhi: Intas Pharmaceutical has got the go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Lupin to focus on development of inhalers with near-zero global warming potential propellants Ruchika Sharma3 Nov 2024 11:00 AM ISTMumbai: Global pharma major Lupin Limited has announced its focus on formulating respiratory inhalers by incorporating a propellant with...
Merck, Moderna begin Phase 3 Trial of V940 with Keytruda in non small lung cancer Ruchika Sharma3 Nov 2024 10:00 AM ISTRahway: Merck, known as MSD outside of the United States and Canada, and Moderna, Inc., announced the initiation of INTerpath-009, a pivotal...
Submit preclinical data in animal and Phase I CT data: CDSCO Panel Tells IQVIA on Pembrolizumab study Dr. Divya Colin2 Nov 2024 6:00 PM ISTNew Delhi: After reviewing the Phase I/III clinical study protocol of the anti-cancer drug Pembrolizumab, the Subject Expert Committee (SEC)...
Pure and Cure Healthcare Gets CDSCO Panel Nod To study Pregabalin, Duloxetine, Methylcobalamin FDC Dr. Divya Colin2 Nov 2024 5:45 PM ISTNew Delhi: Pure and Cure Healthcare has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Shockwave Medical concludes enrollment in all-female coronary IVL study Ruchika Sharma2 Nov 2024 2:16 PM ISTSanta Clara: Shockwave Medical, Inc., part of Johnson & Johnson MedTech has announced the completion of enrollment in EMPOWER CAD, the first...
AbbVie to acquire Aliada Therapeutics for USD 1.4 billion in cash Ruchika Sharma2 Nov 2024 1:00 PM ISTNorth Chicago: AbbVie and Aliada Therapeutics have announced a definitive agreement under which AbbVie will acquire Aliada, a biotechnology...
